Last updated: October 2, 2025
Sponsor: Abramson Cancer Center at Penn Medicine
Overall Status: Completed
Phase
N/A
Condition
N/ATreatment
Tailored
Clinical Study ID
NCT06308081
UPCC 13023
849052
Ages 13-20 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Identify as SGM
ages 13-20
not vaped or used other tobacco products in the past 30 days
have access to a smartphone
Able to read and speak in English
willing to receive messages via texting for the study
susceptible to e-cigarette use at intake (i.e., those do not state "definitely not"to all three susceptibility questions).
Exclusion
Exclusion Criteria:
Current vapers
Non-SGM youth
Study Design
Total Participants: 1155
Treatment Group(s): 1
Primary Treatment: Tailored
Phase:
Study Start date:
February 21, 2024
Estimated Completion Date:
August 15, 2025
Study Description
Connect with a study center
University of Pennsylvania
Philadelphia, Pennsylvania 19104
United StatesSite Not Available
University of Pennsylvania
Philadelphia 4560349, Pennsylvania 6254927 19104
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.